Delivery Order SPE2DB25D3012-SPE2DB25FWVST
Award Date
2/25/25
Potential Completion Date
3/18/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,679.17 firm fixed-price delivery order is for the supply of the prescription drug XALKORI 250 MG CAPSULE 60S. The contract has an ultimate completion date of May 19, 2023 and was awarded on April 28, 2023. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $14,356.89, is a Delivery Order with a Firm Fixed Price pricing type and a completion date of February 12, 2025. The award is for the supply of XALKORI 250 MG CAPSULE 60S, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen holds a significant...
This federal contract award, valued at $12,865.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of XALKORI 200 MG CAPSULE 60S, a pharmaceutical product, with a performance period through December 6, 2024. The contract is not designated as a set-aside and represents an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award, valued at $25,755.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of XALKORI 250 MG CAPSULE 60S, a specialty medication. The contract has an ultimate completion date of November 6, 2024 and is a Firm Fixed Price Delivery Order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $12,865.21 firm-fixed-price contract is for the supply of XALKORI 200 MG CAPSULE 60S, a pharmaceutical product, to support federal healthcare programs. The contract does not have a set-aside designation and has an ultimate completion date of September 24, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $12,877.79 firm fixed price delivery order is for the supply of 4565736120 XALKORI 250 MG CAPSULE 60S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical for delivering a comprehensive range of medical...
This federal contract award is for the delivery of XALKORI 200 MG CAPSULE 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $12,865.21 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 24, 2024, with a completion date of July 16, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product XALKORI 200 MG CAPSULE 60S. The contract, valued at $12,865.21, is a delivery order awarded by the Defense Logistics Agency (DLA) with a completion date of May 14, 2024. The contract is a firm fixed-price arrangement with no set-aside designations. Amerisourcebergen Drug Corp, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation (Amerisourcebergen) for the provision of pharmaceutical products and medical supplies. The contract, valued at up to $12,877.79, is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and runs through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award, valued at $12,679.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XALKORI 250 MG CAPSULE 60S, a pharmaceutical product. This award is not associated with a set-aside program and was made through full and open competition. The prime contractor, AmerisourceBergen Drug Corp, is a subsidiary of Cencora, Inc., a larger pharmaceutical distribution company. This...